BGD Overzicht aandelen
Biogened S.A. ontwikkelt, produceert en distribueert farmaceutische producten in Polen.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 4/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 5/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 2/6 |
Biogened S.A. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | zł23.40 |
| 52 Week Hoogtepunt | zł32.60 |
| 52 Week Laag | zł16.10 |
| Bèta | 0.68 |
| 11 maand verandering | 2.63% |
| 3 maanden verandering | 12.50% |
| 1 Jaar Verandering | 32.20% |
| 33 jaar verandering | 170.52% |
| 5 jaar verandering | 212.00% |
| Verandering sinds IPO | -41.50% |
Recent nieuws en updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Recent updates
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb
Aug 28Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)
Aug 22Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding
May 23Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden
May 09Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations
Feb 21Is Biogened (WSE:BGD) A Risky Investment?
Feb 01Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump
Feb 01We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt
Jun 30Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Oct 08Is Biogened (WSE:BGD) A Risky Investment?
Jun 29Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?
Mar 25These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well
Dec 09Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet
Jul 29Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly
Apr 30Is Biogened (WSE:BGD) A Risky Investment?
Jan 24Rendement voor aandeelhouders
| BGD | PL Pharmaceuticals | PL Markt | |
|---|---|---|---|
| 7D | 0% | -4.8% | -1.2% |
| 1Y | 32.2% | 48.9% | 3.2% |
Rendement versus industrie: BGD underperformed the Polish Pharmaceuticals industry which returned 48.9% over the past year.
Rendement versus markt: BGD exceeded the Polish Market which returned 3.2% over the past year.
Prijsvolatiliteit
| BGD volatility | |
|---|---|
| BGD Average Weekly Movement | 7.1% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in PL Market | 8.5% |
| 10% least volatile stocks in PL Market | 3.1% |
Stabiele aandelenkoers: BGD's share price has been volatile over the past 3 months compared to the Polish market.
Volatiliteit in de loop van de tijd: BGD's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Polish stocks.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 2007 | 218 | Andrzej Grzegorzewski | www.biogened.pl |
Biogened S.A. ontwikkelt, produceert en distribueert farmaceutische producten in Polen. Het bedrijf biedt dermocosmetica aan onder de merknaam Dermedic en thermaal water. Het exporteert ook zijn producten.
Biogened S.A. Samenvatting
| BGD fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | zł57.48m |
| Inkomsten(TTM) | zł5.36m |
| Inkomsten(TTM) | zł105.76m |
10.7x
Koers/Winstverhouding0.5x
P/S-verhoudingIs BGD overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| BGD resultatenrekening (TTM) | |
|---|---|
| Inkomsten | zł105.76m |
| Kosten van inkomsten | zł32.88m |
| Brutowinst | zł72.88m |
| Overige uitgaven | zł67.53m |
| Inkomsten | zł5.36m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Nov 14, 2024
| Winst per aandeel (EPS) | 2.18 |
| Brutomarge | 68.91% |
| Nettowinstmarge | 5.07% |
| Schuld/Eigen Vermogen Verhouding | 54.3% |
Hoe presteerde BGD op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
2.1%
Huidig dividendrendement23%
UitbetalingsratioBetaalt BGD een betrouwbaar dividend?
Zie BGD dividendgeschiedenis en benchmarks| Biogened dividenddata | |
|---|---|
| Ex Dividend Datum | Sep 12 2024 |
| Betaaldatum dividend | Nov 18 2024 |
| Dagen tot Ex-dividend | 53 days |
| Dagen tot dividendbetaaldatum | 14 days |
Betaalt BGD een betrouwbaar dividend?
Zie BGD dividendgeschiedenis en benchmarks